Trial Profile
Effect of Intravenous Pump of Recombinant Human Endostatin Combined With XELOX Chemotherapy, and a Potential Prognostic Biomarkers in Patient With Advanced Colorectal Cancer
Status:
Recruiting
Phase of Trial:
Phase II/III
Latest Information Update: 04 Aug 2021
Price :
$35
*
At a glance
- Drugs Capecitabine (Primary) ; Endostatin (Primary) ; Oxaliplatin (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms EXECC
- 02 Apr 2019 Status changed from not yet recruiting to recruiting.
- 13 Jul 2018 New trial record